Issue 2, 2023

N-Allylbenzimidazole as a strategic surrogate in Rh-catalyzed stereoselective trans-propenylation of aryl C(sp2)–H bond

Abstract

A Rh-catalyzed C(sp2)–H propenylation has been reported by taking N-allyl benzimidazole as an allylamine congener. This transformation has been observed for the first time, where a tandem process of C–H allylation followed by alkene isomerization delivers a highly stereoselective trans-propenylated product. Detailed mechanistic studies including the characterization of rhodacycle-intermediates have been conducted to understand the mechanism.

Graphical abstract: N-Allylbenzimidazole as a strategic surrogate in Rh-catalyzed stereoselective trans-propenylation of aryl C(sp2)–H bond

Supplementary files

Article information

Article type
Communication
Submitted
08 Nov 2022
Accepted
30 Nov 2022
First published
30 Nov 2022

Chem. Commun., 2023,59, 199-202

N-Allylbenzimidazole as a strategic surrogate in Rh-catalyzed stereoselective trans-propenylation of aryl C(sp2)–H bond

P. Biswal, T. Nanda, S. K. Banjare, S. R. Mohanty, R. Mishra and P. C. Ravikumar, Chem. Commun., 2023, 59, 199 DOI: 10.1039/D2CC06048E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements